Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Liu, Fei ^a   Yuan, Ding ^a   Wei, Yonggang ^a   Wang, Wentao ^a   Yan, Lvnan ^a   Wen, Tianfu ^a   Xu, Mingqing ^a   Yang, Jiayin ^a   Li, Bo ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; EPOXIDE HYDROLASE; EPOXIDE HYDROLASE 1; HISTIDINE; TYROSINE; UNCLASSIFIED DRUG; EPHX1 PROTEIN, HUMAN;

AMINO ACID SUBSTITUTION; ARTICLE; BIBLIOGRAPHIC DATABASE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; COLORECTAL CANCER; CONFIDENCE INTERVAL; EMBASE; EPHX1 GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MEDLINE; POPULATION BASED CASE CONTROL STUDY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PUBLISHING; REVIEW;

COLORECTAL NEOPLASMS; EPOXIDE HYDROLASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PUBLICATION BIAS;

EID: 84865284451     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043821     Document Type: Article

References (43)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics.CA Cancer J Clin. 61: 69-90.
2. American Cancer Society (2010) Cancer facts and figures. Available: http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf.
3. Ferlay J, Parkin DM, Steliarova-Foucher E, (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-781.
4. Sung JJ, Lau JY, Goh KL, Leung WK, (2005) Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 6: 871-876.
5. Zhao P, Dai M, Chen W, Li N, (2010) Cancer trends in China. Jpn J Clin Oncol 40: 281-285.
6. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85.
7. Cleary SP, Cotterchio M, Shi E, Gallinger S, Harper P, (2010) Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk. Am J Epidemiol 172: 1000-1014.
8. Norat T, Bingham S, Ferrari P, Slimani N, Jenab M, et al. (2005) Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 97: 906-916.
9. Arand M, Cronin A, Adamska M, Oesch F, (2005) Epoxide hydrolases: structure, function, mechanism, and assay. Methods Enzymol 400: 569-588.
10. Zhang JH, Jin X, Li Y, Wang R, Guo W, et al. (2003) Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China. World J Gastroenterol 9: 2654-2657.
11. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ, (1994) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3: 421-428.
12. Liu L, Liu L, Zeng F, Wang K, Huang J, et al. (2011) Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies. J Cancer Res Clin Oncol 137: 1027-1036.
13. Attia J, Thakkinstian A, D'Este C, (2003) Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 56: 297-303.
14. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta- analyses. BMJ 327: 557-560.
16. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
17. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials.Control Clin Trials. 7: 177-188.
18. Galbraith RF, (1988) A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 7: 889-894.
19. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
20. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
21. Harrison DJ, Hubbard AL, MacMillan J, Wyllie AH, Smith CA, (1999) Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer 79: 168-171.
22. Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, et al. (2002) A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23: 1839-1849.
23. Yu WP (2004) An epidemiological study on environmental exposure factors and genetic polymorphisms of colorectal cancer. Available at: http://dlib3.edu.cnki.net/kns50/detail.aspx?dbname = CMFD2004&filename = 2004062068.nh. [Article in Chinese].
24. Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A, et al. (2005) A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.Pharmacogenet Genomics. 15: 535-546.
25. Robien K, Curtin K, Ulrich CM, Bigler J, Samowitz W, et al. (2005) Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev 14: 1350-1352.
26. Tranah GJ, Chan AT, Giovannucci E, Ma J, Fuchs C, et al. (2005) Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study. Mol Carcinog 44: 21-30.
27. van der Logt EM, Bergevoet SM, Roelofs HM, Te Morsche RH, Dijk Y, et al. (2006) Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.Mutat Res. 593: 39-49.
28. Kiss I, Orsós Z, Gombos K, Bogner B, Csejtei A, et al. (2007) Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Res 27: 2931-2937.
29. Skjelbred CF, Saebø M, Hjartåker A, Grotmol T, Hansteen IL, et al. (2007) Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas.BMC Cancer. 7: 228.
30. Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey AB, et al. (2008) Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.Cancer Epidemiol Biomarkers Prev. 17: 3098-3107.
31. Hlavata I, Vrana D, Smerhovsky Z, Pardini B, Naccarati A, et al. (2010) Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population. Oncol Rep 24: 1347-1353.
32. Nisa H, Budhathoki S, Morita M, Toyomura K, Nagano J, et al. (2012) Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: The Fukuoka Colorectal Cancer Study. Mol Carcinog. Doi: 10.1002/mc.21897. [Epub ahead of print].
33. Sahin O, Arikan S, Oltulu YM, Coskunpinar E, Eren A, et al. (2012) Investigation of a Possible Relationship Between EPHX1 Gene Polymorphisms and Colorectal Cancer in Turkish Society. Genet Test Mol Biomarkers 16: 423-428.
34. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
35. Omiecinski CJ, Hassett C, Hosagrahara V, (2000) Epoxide hydrolase-polymorphism and role in toxicology. Toxicol Lett 112-113: 365-370.
36. Oesch F, (1973) Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3: 305-340.
37. Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A, (1998) Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res 58: 5291-5293.
38. Smith CA, Harrison DJ, (1997) Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350: 630-633.
39. Ma H, Jin G, Hu Z, Zhai X, Chen W, et al. (2006) Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women. Int J Cancer 119: 2173-2178.
40. Li X, Hu Z, Qu X, Zhu J, Li L, et al. (2011) Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysis. PLoS One 6: e14749.
41. Zhao ZQ, Guan QK, Yang FY, Zhao P, Zhou B, et al. (2012) System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.Tumour Biol. 33: 523-535.
42. Benhamou S, Lee WJ, Alexandrie AK, Boffetta P, Bouchardy C, et al. (2002) Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23: 1343-1350.
43. Hassett C, Lin J, Carty CL, Laurenzana EM, Omiecinski CJ, (1997) Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch Biochem Biophys 337: 275-283.